The store will not work correctly when cookies are disabled.
N-(4-chlorophenyl)-8-hydroxyquinoline-5-sulfonamide
ID: ALA5271301
Max Phase: Preclinical
Molecular Formula: C15H11ClN2O3S
Molecular Weight: 334.78
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1ccc(Cl)cc1)c1ccc(O)c2ncccc12
Standard InChI: InChI=1S/C15H11ClN2O3S/c16-10-3-5-11(6-4-10)18-22(20,21)14-8-7-13(19)15-12(14)2-1-9-17-15/h1-9,18-19H
Standard InChI Key: ROHAVZBFQQNXEN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-1.3592 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0737 0.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7881 0.4122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.7881 -0.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0737 -0.8252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3592 -0.4127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0737 1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6452 1.9796 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3592 2.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6448 1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6448 0.8247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0700 0.4119 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.0700 -0.4133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.7853 -0.8261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4990 -0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2159 -0.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2159 -1.6482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5023 -2.0621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7853 -1.6511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7881 -1.9770 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
0.8967 0.4119 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.4826 1.1266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 1 2 0
7 2 1 0
7 8 1 0
9 7 2 0
10 9 1 0
11 10 2 0
1 11 1 0
12 11 1 0
13 12 1 0
14 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 14 2 0
20 17 1 0
12 21 2 0
12 22 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 334.78 | Molecular Weight (Monoisotopic): 334.0179 | AlogP: 3.39 | #Rotatable Bonds: 3 |
Polar Surface Area: 79.29 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.54 | CX Basic pKa: 2.23 | CX LogP: 2.92 | CX LogD: 2.69 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.77 | Np Likeness Score: -1.51 |
References
1. Joaquim AR, Gionbelli MP, Gosmann G, Fuentefria AM, Lopes MS, Fernandes de Andrade S.. (2021) Novel Antimicrobial 8-Hydroxyquinoline-Based Agents: Current Development, Structure-Activity Relationships, and Perspectives., 64 (22.0): [PMID:34779640] [10.1021/acs.jmedchem.1c01318] |